EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Bronchoscopic debridement and antifungal therapy as an effective non-surgical approach to concomitant aspergilloma and ABPA: A case report

Sarah K Yeo, Christina S Thornton iD, Elaine Dumoulin

Therapeutic Advances in Respiratory Disease · 2026-08 · 20

DOI: 10.1177/17534666261480895 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 19.08.2026. Verfasst von Sarah K Yeo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Hauptthemen laut MEDLINE: Antifungal Agents, Debridement, Itraconazole, Bronchoscopy. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary aspergillosis refers to a spectrum of lung diseases caused by Aspergillus species, ranging from allergic manifestations such as allergic bronchopulmonary aspergillosis (ABPA) to chronic and invasive forms, including chronic cavitary pulmonary aspergillosis (CCPA) and aspergilloma. The coexistence of ABPA and aspergilloma is uncommon and poses unique therapeutic challenges, particularly in those unsuitable for surgical intervention. We present the case of a 26-year-old female with CCPA and concomitant ABPA. Despite prolonged antifungal therapy, imaging revealed a persistent left upper lobe aspergilloma accompanied by elevated total and Aspergillus -specific IgE levels. She subsequently underwent bronchoscopic debridement with peri-procedural itraconazole. Following the procedure, she demonstrated significant clinical and immunologic improvement, with more than a 20% reduction in IgE levels and normalization of pulmonary function, which had previously shown a restrictive pattern. This case highlights that a multimodal, minimally invasive approach integrating bronchoscopic debridement with peri-procedural antifungal therapy, offers a viable and effective alternative for non-surgical candidates, promoting both functional and immunologic recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsDebridementItraconazoleBronchoscopyAspergillosis, Allergic BronchopulmonaryHumansFemaleTreatment OutcomeAdultCombined Modality Therapy

Stichwörter der Autor:innen

allergic bronchopulmonary aspergillosisaspergillomabronchoscopic debridementcase reportpulmonary aspergilloma

Substanzen

Antifungal AgentsItraconazole

Autor:innen und Institutionen

  • Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.

ORCID-Profile: Christina S Thornton

Zitieren

APA

Yeo, S. K., Thornton, C. S., & Dumoulin, E. (2026). Bronchoscopic debridement and antifungal therapy as an effective non-surgical approach to concomitant aspergilloma and ABPA: A case report. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261480895

Vancouver

Yeo SK, Thornton CS, Dumoulin E. Bronchoscopic debridement and antifungal therapy as an effective non-surgical approach to concomitant aspergilloma and ABPA: A case report. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261480895

BibTeX
@article{Yeo2026,
  author = {Yeo, Sarah K and Thornton, Christina S and Dumoulin, Elaine},
  title = {Bronchoscopic debridement and antifungal therapy as an effective non-surgical approach to concomitant aspergilloma and ABPA: A case report},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2026},
  volume = {20},
  doi = {10.1177/17534666261480895}
}
Kostenlos starten →